Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

The Global Prefilled Syringes Market is expected to witness a high single-digit growth rate by 2027. The growth of the prefilled syringes market is driven by an increasing prevalence of diverse ...

FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.

The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Prefilled Syringes Market Industry Report 2025, by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Barrel Material, Number of Barrel ...

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...

The prefilled syringe reduces administration steps for patients using Cortrophin Gel, which remains available in 5 mL and 1 mL vials. The company noted that the new prefilled syringe reduces the ...

The Global Prefilled Syringes Market was valued at $5.43 billion in 2022 and is projected to reach $10.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.70% during the forecast ...

DUBLIN--(BUSINESS WIRE)--Oct 14, 2024-- ...

The audit details a total of 623 vials of controlled substances missing from inventory logs during the audit period — June 2021 through July 2022 — including 242 vials of Dilaudid ... with 16 missing ...